These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 21766137)

  • 21. 5-Fluorouracil drug alters the microRNA expression profiles in MCF-7 breast cancer cells.
    Shah MY; Pan X; Fix LN; Farwell MA; Zhang B
    J Cell Physiol; 2011 Jul; 226(7):1868-78. PubMed ID: 21506117
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The roles of microRNA in cancer and apoptosis.
    Lynam-Lennon N; Maher SG; Reynolds JV
    Biol Rev Camb Philos Soc; 2009 Feb; 84(1):55-71. PubMed ID: 19046400
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Differential expression profiling of microRNAs and their potential involvement in renal cell carcinoma pathogenesis.
    Chow TF; Youssef YM; Lianidou E; Romaschin AD; Honey RJ; Stewart R; Pace KT; Yousef GM
    Clin Biochem; 2010 Jan; 43(1-2):150-8. PubMed ID: 19646430
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Differentially regulated micro-RNAs and actively translated messenger RNA transcripts by tumor suppressor p53 in colon cancer.
    Xi Y; Shalgi R; Fodstad O; Pilpel Y; Ju J
    Clin Cancer Res; 2006 Apr; 12(7 Pt 1):2014-24. PubMed ID: 16609010
    [TBL] [Abstract][Full Text] [Related]  

  • 25. MicroRNA-185 suppresses tumor growth and progression by targeting the Six1 oncogene in human cancers.
    Imam JS; Buddavarapu K; Lee-Chang JS; Ganapathy S; Camosy C; Chen Y; Rao MK
    Oncogene; 2010 Sep; 29(35):4971-9. PubMed ID: 20603620
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Involvement of microRNAs in breast cancer.
    Adams BD; Guttilla IK; White BA
    Semin Reprod Med; 2008 Nov; 26(6):522-36. PubMed ID: 18951334
    [TBL] [Abstract][Full Text] [Related]  

  • 27. MicroRNAs and cancer.
    Cowland JB; Hother C; Grønbaek K
    APMIS; 2007 Oct; 115(10):1090-106. PubMed ID: 18042145
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Genome-wide profiling of chromatin signatures reveals epigenetic regulation of MicroRNA genes in colorectal cancer.
    Suzuki H; Takatsuka S; Akashi H; Yamamoto E; Nojima M; Maruyama R; Kai M; Yamano HO; Sasaki Y; Tokino T; Shinomura Y; Imai K; Toyota M
    Cancer Res; 2011 Sep; 71(17):5646-58. PubMed ID: 21734013
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Metastasis-related miRNAs, active players in breast cancer invasion, and metastasis.
    Shi M; Liu D; Duan H; Shen B; Guo N
    Cancer Metastasis Rev; 2010 Dec; 29(4):785-99. PubMed ID: 20938719
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Integrative analysis of microRNA, mRNA and aCGH data reveals asbestos- and histology-related changes in lung cancer.
    Nymark P; Guled M; Borze I; Faisal A; Lahti L; Salmenkivi K; Kettunen E; Anttila S; Knuutila S
    Genes Chromosomes Cancer; 2011 Aug; 50(8):585-97. PubMed ID: 21563230
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Identification and characterization of microRNAs expressed in human breast cancer T-47D cells in response to prolactin treatment by Solexa deep-sequencing technology.
    Wei Q; He W; Yao J; Guo L; Lu Y; Cao X
    Biochem Biophys Res Commun; 2013 Mar; 432(3):480-7. PubMed ID: 23410749
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The TGFβ-signaling pathway and colorectal cancer: associations between dysregulated genes and miRNAs.
    Pellatt AJ; Mullany LE; Herrick JS; Sakoda LC; Wolff RK; Samowitz WS; Slattery ML
    J Transl Med; 2018 Jul; 16(1):191. PubMed ID: 29986714
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A systematic study on dysregulated microRNAs in cervical cancer development.
    He Y; Lin J; Ding Y; Liu G; Luo Y; Huang M; Xu C; Kim TK; Etheridge A; Lin M; Kong D; Wang K
    Int J Cancer; 2016 Mar; 138(6):1312-27. PubMed ID: 26032913
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The roles of oncogenic miRNAs and their therapeutic importance in breast cancer.
    O'Bryan S; Dong S; Mathis JM; Alahari SK
    Eur J Cancer; 2017 Feb; 72():1-11. PubMed ID: 27997852
    [TBL] [Abstract][Full Text] [Related]  

  • 35. miRNA-21 inhibition enhances RANTES and IP-10 release in MCF-7 via PIAS3 and STAT3 signalling and causes increased lymphocyte migration.
    Wang Z; Han J; Cui Y; Zhou X; Fan K
    Biochem Biophys Res Commun; 2013 Sep; 439(3):384-9. PubMed ID: 23998932
    [TBL] [Abstract][Full Text] [Related]  

  • 36. miRNA dysregulation in breast cancer.
    Mulrane L; McGee SF; Gallagher WM; O'Connor DP
    Cancer Res; 2013 Nov; 73(22):6554-62. PubMed ID: 24204025
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Meta-analysis of the differentially expressed breast cancer-related microRNA expression profiles.
    Wu J; Lu P; Yang T; Wang L
    J Obstet Gynaecol; 2014 Oct; 34(7):630-3. PubMed ID: 24922277
    [TBL] [Abstract][Full Text] [Related]  

  • 38. MicroRNA expression profiling in male and female familial breast cancer.
    Pinto R; De Summa S; Danza K; Popescu O; Paradiso A; Micale L; Merla G; Palumbo O; Carella M; Tommasi S
    Br J Cancer; 2014 Dec; 111(12):2361-8. PubMed ID: 25393370
    [TBL] [Abstract][Full Text] [Related]  

  • 39. MicroRNA dysregulation during chemical carcinogenesis.
    Pogribny IP
    Epigenomics; 2009 Dec; 1(2):281-90. PubMed ID: 22122703
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Integrative Analysis with Monte Carlo Cross-Validation Reveals miRNAs Regulating Pathways Cross-Talk in Aggressive Breast Cancer.
    Colaprico A; Cava C; Bertoli G; Bontempi G; Castiglioni I
    Biomed Res Int; 2015; 2015():831314. PubMed ID: 26240829
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.